Last updated: April 26, 2026 Biotechnology in 2026 has reached an inflection point. Gene therapies are reaching organs once thought untouchable, decades-old “undruggable” cancer targets are finally falling, CRISPR base editing is correcting mutations that traditional gene editing couldn’t touch, AI agents are autonomously designing new drug candidates, and even contact lenses are becoming pharmacies. … Read more
If you’ve followed semiconductor or AI news in the past year, three letters keep popping up: HBM. SK Hynix’s stock doubles. Samsung pours billions into a new fab line. NVIDIA can’t get enough supply. And at the center of every headline sits this mysterious acronym — High Bandwidth Memory. Yet most people, even seasoned investors, … Read more
In late March 2026, Anthropic — the AI safety–focused company behind the Claude family of models — suffered two consecutive security lapses that exposed internal files and the full source code of its flagship developer tool, Claude Code. Here’s a summary of what happened, how the company responded, and why it matters. Incident 1: Internal … Read more
At ECONPLEX, technology is the backbone that powers our mission to deliver real-time economic intelligence across the globe. In this post, we share our technology vision and roadmap — where we are today and where we’re headed. 🏗️ Architecture Philosophy Our platform is built on three core principles: Real-Time First — Data should reflect the … Read more